Analysis of Electrocardiographic Criteria of Right Ventricular Hypertrophy in Patients with Chronic Thromboembolic Pulmonary Hypertension before and after Balloon Pulmonary Angioplasty

Background: Chronic thromboembolic pulmonary hypertension (CTEPH) may lead to typical electrocardiographic changes that can be reversed by balloon pulmonary angioplasty (BPA). The aim of this study was to investigate the significance of rarely used electrocardiogram (ECG) parameters, possible electr...

Full description

Bibliographic Details
Main Authors: Lukas Ley, Christoph B. Wiedenroth, Hossein Ardeschir Ghofrani, Reinhard Hoeltgen, Dirk Bandorski
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/12/13/4196
_version_ 1797591498718445568
author Lukas Ley
Christoph B. Wiedenroth
Hossein Ardeschir Ghofrani
Reinhard Hoeltgen
Dirk Bandorski
author_facet Lukas Ley
Christoph B. Wiedenroth
Hossein Ardeschir Ghofrani
Reinhard Hoeltgen
Dirk Bandorski
author_sort Lukas Ley
collection DOAJ
description Background: Chronic thromboembolic pulmonary hypertension (CTEPH) may lead to typical electrocardiographic changes that can be reversed by balloon pulmonary angioplasty (BPA). The aim of this study was to investigate the significance of rarely used electrocardiogram (ECG) parameters, possible electrocardiographic differences between residual and significantly improved CTEPH and the role of electrocardiographic parameters in low mPAP (mean pulmonary arterial pressure) ranges since the mPAP threshold for the definition of pulmonary hypertension has recently been adjusted (≥25 mmHg to >20 mmHg). Material and Methods: Between March 2014 and October 2020, 140 patients with CTEPH and 10 with CTEPD (chronic thromboembolic pulmonary disease) without pulmonary hypertension (PH) were retrospectively enrolled (12-lead ECG and right heart catheterization before and 6 months after BPA). The ECG parameters of right heart strain validated by studies and clinical experience were evaluated. Special attention was paid to six specific ECG parameters. After BPA, the cohort was divided into subgroups to investigate possible electrocardiographic differences with regard to the haemodynamic result. Results: The present study confirmed that the typical electrocardiographic signs of CTEPH can be found on an ECG, can regress after BPA and partially correlate well with haemodynamic parameters. “R V1, V2 + S I, aVL − S V1” was a parameter of particular note. BPA reduced its frequency (47% vs. 29%) statistically significantly after Bonferroni correction (<i>p</i> < 0.001). Moreover, it showed a good correlation with mPAP and PVR (r-values: 0.372–0.519, <i>p</i>-values: < 0.001). Exceeding its cut-off value before therapy was associated with more severe CTEPH before therapy (higher mPAP, PVR, NT-pro-BNP and troponin and lower TAPSE) and an increased risk of death. Exceeding its cut-off value before and after therapy was associated with more severe CTEPH after therapy (higher RAP, mPAP, PVR, NT-pro-BNP and NYHA class) and an increased risk of death. Men tend to be affected more frequently. After subgrouping, it was observed that a higher median mPAP was associated with a higher right atrial pressure (RAP), a higher pulmonary vascular resistance (PVR) and a lower cardiac output (CO) before and after BPA. In addition, under these conditions, more and more severe electrocardiographic pathologies were detected before and after BPA. Some patients with low mPAP also continued to show mild ECG changes after BPA. In some cases, very few to no pathological ECG changes were detected, and the ECG could present as mostly normal in some patients (5% before BPA and 13% after BPA). Conclusion: “R V1, V2 + S I, aVL − S V1” seems to be able to support the diagnosis of CTEPH, indicate therapeutic improvement and estimate haemodynamics. It also seems capable of predicting a (persistent) severe disease with probably increased need for therapy and increased mortality. Mild PH has been observed to have either no or few mild ECG changes. This might complicate the (early) detection of PH.
first_indexed 2024-03-11T01:38:18Z
format Article
id doaj.art-a0dfcefe815e461da4c9199dfd5ebd49
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-11T01:38:18Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-a0dfcefe815e461da4c9199dfd5ebd492023-11-18T16:50:23ZengMDPI AGJournal of Clinical Medicine2077-03832023-06-011213419610.3390/jcm12134196Analysis of Electrocardiographic Criteria of Right Ventricular Hypertrophy in Patients with Chronic Thromboembolic Pulmonary Hypertension before and after Balloon Pulmonary AngioplastyLukas Ley0Christoph B. Wiedenroth1Hossein Ardeschir Ghofrani2Reinhard Hoeltgen3Dirk Bandorski4Campus Kerckhoff, Justus-Liebig-University Giessen, 61231 Bad Nauheim, GermanyKerckhoff Heart and Thorax Center, Department of Thoracic Surgery, 61231 Bad Nauheim, GermanyUniversities of Giessen and Marburg Lung Center (UGMLC), 35392 Giessen, GermanyKlinikum Westmünsterland, 46397 Bocholt, GermanyFaculty of Medicine, Semmelweis University Campus Hamburg, 20099 Hamburg, GermanyBackground: Chronic thromboembolic pulmonary hypertension (CTEPH) may lead to typical electrocardiographic changes that can be reversed by balloon pulmonary angioplasty (BPA). The aim of this study was to investigate the significance of rarely used electrocardiogram (ECG) parameters, possible electrocardiographic differences between residual and significantly improved CTEPH and the role of electrocardiographic parameters in low mPAP (mean pulmonary arterial pressure) ranges since the mPAP threshold for the definition of pulmonary hypertension has recently been adjusted (≥25 mmHg to >20 mmHg). Material and Methods: Between March 2014 and October 2020, 140 patients with CTEPH and 10 with CTEPD (chronic thromboembolic pulmonary disease) without pulmonary hypertension (PH) were retrospectively enrolled (12-lead ECG and right heart catheterization before and 6 months after BPA). The ECG parameters of right heart strain validated by studies and clinical experience were evaluated. Special attention was paid to six specific ECG parameters. After BPA, the cohort was divided into subgroups to investigate possible electrocardiographic differences with regard to the haemodynamic result. Results: The present study confirmed that the typical electrocardiographic signs of CTEPH can be found on an ECG, can regress after BPA and partially correlate well with haemodynamic parameters. “R V1, V2 + S I, aVL − S V1” was a parameter of particular note. BPA reduced its frequency (47% vs. 29%) statistically significantly after Bonferroni correction (<i>p</i> < 0.001). Moreover, it showed a good correlation with mPAP and PVR (r-values: 0.372–0.519, <i>p</i>-values: < 0.001). Exceeding its cut-off value before therapy was associated with more severe CTEPH before therapy (higher mPAP, PVR, NT-pro-BNP and troponin and lower TAPSE) and an increased risk of death. Exceeding its cut-off value before and after therapy was associated with more severe CTEPH after therapy (higher RAP, mPAP, PVR, NT-pro-BNP and NYHA class) and an increased risk of death. Men tend to be affected more frequently. After subgrouping, it was observed that a higher median mPAP was associated with a higher right atrial pressure (RAP), a higher pulmonary vascular resistance (PVR) and a lower cardiac output (CO) before and after BPA. In addition, under these conditions, more and more severe electrocardiographic pathologies were detected before and after BPA. Some patients with low mPAP also continued to show mild ECG changes after BPA. In some cases, very few to no pathological ECG changes were detected, and the ECG could present as mostly normal in some patients (5% before BPA and 13% after BPA). Conclusion: “R V1, V2 + S I, aVL − S V1” seems to be able to support the diagnosis of CTEPH, indicate therapeutic improvement and estimate haemodynamics. It also seems capable of predicting a (persistent) severe disease with probably increased need for therapy and increased mortality. Mild PH has been observed to have either no or few mild ECG changes. This might complicate the (early) detection of PH.https://www.mdpi.com/2077-0383/12/13/4196PHpulmonary hypertensionCTEPHchronic thromboembolic pulmonary hypertensionBPAballoon pulmonary angioplasty
spellingShingle Lukas Ley
Christoph B. Wiedenroth
Hossein Ardeschir Ghofrani
Reinhard Hoeltgen
Dirk Bandorski
Analysis of Electrocardiographic Criteria of Right Ventricular Hypertrophy in Patients with Chronic Thromboembolic Pulmonary Hypertension before and after Balloon Pulmonary Angioplasty
Journal of Clinical Medicine
PH
pulmonary hypertension
CTEPH
chronic thromboembolic pulmonary hypertension
BPA
balloon pulmonary angioplasty
title Analysis of Electrocardiographic Criteria of Right Ventricular Hypertrophy in Patients with Chronic Thromboembolic Pulmonary Hypertension before and after Balloon Pulmonary Angioplasty
title_full Analysis of Electrocardiographic Criteria of Right Ventricular Hypertrophy in Patients with Chronic Thromboembolic Pulmonary Hypertension before and after Balloon Pulmonary Angioplasty
title_fullStr Analysis of Electrocardiographic Criteria of Right Ventricular Hypertrophy in Patients with Chronic Thromboembolic Pulmonary Hypertension before and after Balloon Pulmonary Angioplasty
title_full_unstemmed Analysis of Electrocardiographic Criteria of Right Ventricular Hypertrophy in Patients with Chronic Thromboembolic Pulmonary Hypertension before and after Balloon Pulmonary Angioplasty
title_short Analysis of Electrocardiographic Criteria of Right Ventricular Hypertrophy in Patients with Chronic Thromboembolic Pulmonary Hypertension before and after Balloon Pulmonary Angioplasty
title_sort analysis of electrocardiographic criteria of right ventricular hypertrophy in patients with chronic thromboembolic pulmonary hypertension before and after balloon pulmonary angioplasty
topic PH
pulmonary hypertension
CTEPH
chronic thromboembolic pulmonary hypertension
BPA
balloon pulmonary angioplasty
url https://www.mdpi.com/2077-0383/12/13/4196
work_keys_str_mv AT lukasley analysisofelectrocardiographiccriteriaofrightventricularhypertrophyinpatientswithchronicthromboembolicpulmonaryhypertensionbeforeandafterballoonpulmonaryangioplasty
AT christophbwiedenroth analysisofelectrocardiographiccriteriaofrightventricularhypertrophyinpatientswithchronicthromboembolicpulmonaryhypertensionbeforeandafterballoonpulmonaryangioplasty
AT hosseinardeschirghofrani analysisofelectrocardiographiccriteriaofrightventricularhypertrophyinpatientswithchronicthromboembolicpulmonaryhypertensionbeforeandafterballoonpulmonaryangioplasty
AT reinhardhoeltgen analysisofelectrocardiographiccriteriaofrightventricularhypertrophyinpatientswithchronicthromboembolicpulmonaryhypertensionbeforeandafterballoonpulmonaryangioplasty
AT dirkbandorski analysisofelectrocardiographiccriteriaofrightventricularhypertrophyinpatientswithchronicthromboembolicpulmonaryhypertensionbeforeandafterballoonpulmonaryangioplasty